XBIO - Xenetic Biosciences, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
5.12 -0.31 (-6.05%)	---	0.0 (0.0%)	0.0 (0.0%)	0.13 (2.54%)	-0.31 (-6.05%)	0.0 (0.0%)	0.0 (0.0%)

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.45
Diluted EPS:: -0.45
Basic P/E:: -10.6889
Diluted P/E:: -10.6889
RSI(14) 1m:: 100.0
VWAP:: 4.81
RVol:: 0.0771

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	4.88 +0.07 (+1.46%)	Oct 15 15:50
1m	Price increase 1m	4.84 +0.13 (+2.73%)	Oct 15 15:21
1m	Price increase 1m	4.84 +0.08 (+1.79%)	Oct 15 15:16
1m	Price increase 1m	4.7 +0.05 (+1.08%)	Oct 15 14:46
10m	Price decrease 10m	4.57 -0.15 (-3.27%)	Oct 15 14:37